Summary: President Donald Trump’s tariffs on Mexican, Canadian, and Chinese imports took effect, sparking a trade war with the U.S.’s three largest trading partners. The tariffs include a 25% levy on Mexican and Canadian goods and an additional 10% tax on Chinese imports, raising the total tariff on those products […]
Pfizer, BioNTech, and Moderna Have Lost a Combined Market Capitalization of $418,887,461,200
Shockingly, the combined loss in market capitalization since late 2021 of Pfizer, Moderna, and BioNTech now exceeds the Gross Domestic Product (GDP) of Malaysia, South Africa, Denmark, the Philippines, Hong Song SAR, Columbia, Chile, the Czech Republic, Portugal, Finland, Greece, Hungary, Kuwait, Puerto Rico, Luxembourg, and most other countries. That […]
Report 63: In Q3 2022, Pfizer Wrote Off $450 Million of Expired or Expiring COVID-19-Related Inventory.
Despite generating over $100 billion in revenue in 2022, Pfizer’s stock has dropped precipitously. Pfizer’s revenue was relatively flat, hovering between $41 billion and $51 billion, from 2014 to 2020. Then, its mRNA COVID-19 “vaccine” was awarded Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) on December […]